Lung Cancer / Thoracic Oncology
Contact Info
-
+123+456-7890 -
sarahlee@prohealth.com
Appointment Schedules
- Monday 09.00-12.00
- Wednesday 15.00-18.00
- Friday 09.00-12.00
Dr. Shirish Gadgeel
MD
Professor in the Department of Internal Medicine, Chief of Division of Hematology and Oncology, Associate Director of Patient Experience and Clinical Care, Henry Ford Cancer Institute, Detroit USA
Degrees
-
University of California, San Francisco.
Medical degree
-
University of California, Los Angeles (UCLA) Medical Center.
Completed residency training in psychiatry
-
University of California, Berkeley.
Master of Public Health degree
Experiences
-
Worked in community mental health clinics, private practice, and academic medical centers.
-
Expertise in the treatment of mood disorders, anxiety disorders, and psychotic disorders.
-
Special interest in womens mental health and perinatal psychiatry.
-
Experience managing complex cases that involve both mental health and medical issues.
Awards/Achievements
-
Fellow of the American Psychiatric Association (FAPA).
-
Recognized for research contributions with grants from the National Institute of Mental Health (NIMH) and the American Foundation for Suicide Prevention.
Dr. Gadgeel served as director of the Thoracic Oncology Program and co-leader of Molecular Therapeutics Program at Karmanos Cancer Institute. After graduating with his MBBS medical degree from the University of Bombay in Mumbai, India, he completed his Internal Medicine residency in Mumbai. He also completed an internship at LaGuardia Hospital (now Long Island Jewish Forest Hills), as well as his Hematology/Oncology residency and Bone Marrow Transplantation Fellowship at Wayne State University. Following his fellowship, Dr. Gadgeel served as director of the Thoracic Oncology Program and co-leader of Molecular Therapeutics Program at Karmanos Cancer Institute. Prior to Henry Ford, Dr. Gadgeel was a professor in the Department of Internal Medicine and the Mary Lou Kennedy Research Professor in Thoracic Oncology at the University of Michigan/Michigan Medicine.
His clinical research experience spans 20 years. He is also a member of the steering committee of the Lung Cancer Committee of Southwest Oncology Group. He is the Associate Editor of Clinical Lung Cancer and a reviewer for many journals, including Clinical Cancer Research, Journal of Clinical Oncology, Lancet Oncology, and Journal of Thoracic Oncology. He has served as faculty for the annual meeting of the American Society of Clinical Oncology (ASCO) and as a member of the education committee of ASCO. He is a member of the Communications committee of the International Association of Study of Lung Cancer (IASLC). He was awarded by the National Cancer Institute the Cancer Clinical Investigator Team Leadership Award in 2012.
